Genoway (ALGEN) — Cash Flow Reinvestment Rate
Latest as of December 2024:
0.44x
Genoway (ALGEN) has a Cash Flow Reinvestment Rate of 0.44x as of December 2024, reinvesting €2.39 Million (capex €2.39 Million ) from operating cash flow of €5.38 Million. See ALGEN cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.44x
(Capex + Investments) / Operating CF
Total Reinvested
€2.39 Million
Capex + Investments
Operating Cash Flow
€5.38 Million
EUR
Capital Expenditures
€2.39 Million
EUR
Genoway Cash Flow Reinvestment Rate (2009–2024)
Historical reinvestment intensity for Genoway across 12 annual periods. For the full cash flow conversion analysis, see Genoway cash flow conversion.
Annual Cash Flow Reinvestment Rate for Genoway (2009–2024)
Year-by-year capital reinvestment analysis for Genoway. See ALGEN FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.97x | €5.24 Million | €5.38 Million | €2.39 Million | ▼ -21.1% |
| 2023 | 1.23x | €3.78 Million | €3.06 Million | €1.78 Million | ▼ -24.6% |
| 2022 | 1.64x | €3.86 Million | €2.36 Million | €1.92 Million | ▼ -34.1% |
| 2019 | 2.49x | €2.93 Million | €1.18 Million | €2.70 Million | ▼ -28.2% |
| 2018 | 3.46x | €2.93 Million | €847.03K | €2.70 Million | ▼ -26.7% |
| 2017 | 4.72x | €2.93 Million | €620.94K | €2.70 Million | ▲ +633.8% |
| 2015 | 0.64x | €547.88K | €851.08K | €161.06K | ▼ -82.4% |
| 2014 | 3.66x | €733.41K | €200.29K | €47.66K | ▲ +1214.2% |
| 2013 | 0.28x | €237.63K | €852.87K | €100.41K | ▼ -18.8% |
| 2011 | 0.34x | €254.35K | €741.51K | €254.35K | ▼ -12.2% |
| 2010 | 0.39x | €357.19K | €914.07K | €357.19K | ▲ +14034.6% |
| 2009 | 0.00x | €4.98K | €1.80 Million | €4.98K | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow